Elevated expressions of osteopontin and tenascin C in ascending aortic aneurysms are associated with trileaflet aortic valves as compared with bicuspid aortic valves

Cardiovascular Pathology

Volumn 16, Issue 3, 2007, Pages 144-150

  Majumdar, Ramanath ^a   Miller, Dylan V ^a   Ballman, Karla V ^a   Unnikrishnan, Gopinathan ^a   McKellar, Stephen H ^a   Sarkar, Gobinda ^a   Sreekumar, Raghavakaimal ^a   Bolander, Mark E ^a   Sundt III, Thoralf M ^a  

^a MAYO CLINIC   (United States)

Author keywords

Aneurysm; Ascending aorta; Gene expression; Immunohistochemistry

Indexed keywords

MESSENGER RNA; OSTEOPONTIN; TENASCIN;

ADULT; AORTA ANEURYSM; AORTA VALVE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; MITRAL VALVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE; STAINING;

AORTA; AORTIC ANEURYSM; AORTIC VALVE; BIOLOGICAL MARKERS; GENE EXPRESSION; HUMANS; MIDDLE AGED; OSTEOPONTIN; RNA, MESSENGER; TENASCIN; TISSUE ARRAY ANALYSIS;

EID: 34248375992     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carpath.2006.12.001     Document Type: Article

References (32)

1. Clouse W., Hallett J., Schaff H., Gayari M., Ilstrup D., and Melton L. Improved prognosis of thoracic aortic aneurysms: a population-based study. JAMA 280 (1998) 1926-1929
2. Mehta R., Suzuki T., Hagan P., et al. Predicting death in patients with acute type A aortic dissection. Circulation 105 (2002) 200-206
3. Roberts W. The congenitally bicuspid aortic valve. A study of 95 autopsy cases. Am J Cardiol 26 (1970) 72-83
4. Ward C. Clinical significance of the bicuspid aortic valve. Heart 83 (2000) 81-85
5. Cecconi M., Manfrin M., Moraca A., Zanoli R., Colonna P., and Bettuzzi M. Aortic dimensions in patients with bicuspid aortic valve without significant valve dysfunction. Am J Cardiol 95 (2005) 292-294
6. Beroukhim R., Kruzick T., Taylor A., Gao D., and Yetman A. Progression of aortic dilation in children with a functionally normal bicuspid aortic valve. Am J Cardiol 98 (2006) 828-830
7. Yasuda H., Nakatani S., Stugaard M., et al. Failure to prevent progressive dilation of ascending aorta by aortic valve replacement in patients with bicuspid aortic valve: comparison with trileaflet aortic valve. Circulation 108 (2003) II291-II294
8. Sabet H., Edwards W., Tazelaar H., and Daly R. Congenitally bicuspid aortic valves: a surgical pathology study of 542 cases (1991 through 1996) and a literature review of 2,715 additional cases. Mayo Clin Proc 74 (1999) 14-26
9. Larson E., and Edwards W. Risk factors for aortic dissection: a necropsy study of 161 cases. Am J Cardiol 53 (1984) 849-855
10. Keane M., Wiegers S., Plappert T., Pochettino A., Bavaria J., and Sutton M. Bicuspid aortic valves are associated with aortic dilatation out of proportion to coexistent valvular lesions. Circulation 102 (2000) 35-39
11. Bonderman D., Gharehbaghi-Schell E., Wollenek G., Maurer G., Baumgartner H., and Lang I. Mechanisms underlying aortic dilatation in congenital aortic valve malformation. Circulation 99 (1999) 2138-2143
12. Fedak P., de Sa M., Verma S., Nili N., Kazemian P., Butany J., et al. Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilatation. J Thorac Cardiovasc Surg 126 (2003) 797-806
13. Nataatmadja M., West M., West J., Summers K., Walker P., Nagata M., and Watanabe T. Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth muscle cells in Marfan syndrome and bicuspid aortic valve thoracic aortic aneurysm. Circulation 108 (2003) II-329-II-334
14. Nistri S., Sorbo M., Basso C., and Thiene G. Bicuspid aortic valve: abnormal aortic elastic properties. J Heart Valve Dis 11 (2002) 369-373
15. Koullias G., Korkolisa D., Ravichandran P., Psyrri A., Hatzarasa I., and Elefteriades J. Tissue microarray detection of matrix metalloproteinases in diseased tricuspid and bicuspid aortic valves with or without pathology of the ascending aorta. Eur J Cardiothorac Surg 26 (2004) 1098-1103
16. Boyum J., Fellinger E., Schmoker J., Trombley L., McPartland K., Ittleman F., et al. Matrix metalloproteinase activity in thoracic aortic aneurysms associated with bicuspid and tricuspid aortic valves. J Thorac Cardiovasc Surg 127 (2004) 686-691
17. LeMaire S., Wang X., Wilks J., Carter S., Wen S., Won T., et al. Matrix metalloproteinases in ascending aortic aneurysms: bicuspid versus trileaflet aortic valves. J Surg Res 123 (2005) 40-48
18. Loeys B., Schwarze U., Holm T., Callewaert B., Thomas G., Pannu H., et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 355 (2006) 788-798
19. Schellings M., Pinto Y., and Heymans S. Matricellular proteins in the heart: possible role during stress and remodeling. Cardiovasc Res 64 (2004) 24-31
20. Lesauskaite V., Tanganelli P., Sassi C., Neri E., Diciolla F., Ivanoviene L., et al. Smooth muscle cells of the media in the dilatative pathology of ascending thoracic aorta: morphology, immunoreactivity for osteopontin, matrix metalloproteinases, and their inhibitors. Hum Pathol 32 (2001) 1003-1011
21. Van Vickle-Chavez S., Tung W., Absi T., Ennis T., Mao D., Cobb J., et al. Temporal changes in mouse aortic wall gene expression during the development of elastase-induced abdominal aortic aneurysms. J Vasc Surg 43 (2006) 1010-1020
22. Paik D., Fu C., Bhattacharya J., and Tilson D. Ongoing angiogenesis in blood vessels of the abdominal aortic aneurysm. Exp Mol Med 36 (2004) 524-533
23. Lesauskaite V., Epistolato M., Castagnini M., Urbonavicius S., and Tanganelli P. Expression of matrix metalloproteinases, their tissue inhibitors, and osteopontin in the wall of thoracic and abdominal aortas with dilatative pathology. Hum Pathol 37 (2006) 1076-1084
24. Seipelt R., Backer C., Mavroudis C., Stellmach V., Cornwell M., Seipelt I., et al. Local delivery of osteopontin attenuates vascular remodeling by altering matrix metalloproteinase-2 in a rabbit model of aortic injury. J Thorac Cardiovasc Surg 130 (2005) 355-362
25. Lai C., Seshadri V., Huang K., Shao J., Cai J., Vattikuti R., et al. An osteopontin-NADPH oxidase signaling cascade promotes pro-matrix metalloproteinase 9 activation in aortic mesenchymal cells. Circ Res 98 (2006) 1479-1489
26. Chiquet-Ehrismann R., and Chiquet M. Tenascins: regulation and putative functions during pathological stress. J Pathol 200 (2003) 488-499
27. Wallner K., Li C., Shah P., Wu K., Schwartz S., and Sharifi B. EGF-like domain of tenascin-C is proapoptotic for cultured smooth muscle cells. Arterioscler Thromb Vasc Biol 24 (2004) 1416-1421
28. Okamoto R., Xu H., Kouchoukos N., Moon M., and Sundt T. The influence of mechanical properties on wall stress and distensibility of the dilated ascending aorta. J Thorac Cardiovasc Surg 126 (2003) 842-850
29. Koullias G., Modak R., Tranquilli M., Korkolis D., Barash P., and Elefteriades J. Mechanical deterioration underlies malignant behavior of aneurysmal human ascending aorta. J Thorac Cardiovasc Surg 130 (2005) 677-683
30. Wang X., LeMaire S., Chen L., Wu K., Schwartz S., and Sharifi B. Increased collagen deposition and elevated expression of connective tissue growth factor in human thoracic aortic dissection. Circulation 114 (2006) I200-I205
31. Goriounov D., Leung C., and Liem R. Protein products of human Gas2-related genes on chromosomes 17 and 22 (hGAR17 and hGAR22) associate with both microfilaments and microtubules. J Cell Sci 116 (2003) 1045-1058
32. Behar O., Golden J., Mashimo H., Schoen F., and Fishman M. Semaphorin III is needed for normal patterning and growth of nerves, bones and heart. Nature 383 (1996) 525-528